Last updated: March 31, 2026
In this article
- What Is Pimobendan?
- When Do Veterinarians Prescribe Pimobendan?
- How Pimobendan Is Dosed
- What the Research Shows: Survival Benefits
- Side Effects and Safety Considerations
- Pimobendan as Part of a Multi-Drug Protocol
- Living with a Dog on Pimobendan
- Breeds Most Commonly Prescribed Pimobendan
- Frequently Asked Questions
Pimobendan (Vetmedin) for Dogs: The Heart Failure Drug That Extends Life
If your dog has been diagnosed with heart disease, there is a good chance your veterinarian has mentioned pimobendan. Sold under the brand name Vetmedin, this medication has fundamentally changed how veterinary cardiologists manage congestive heart failure in dogs — and the clinical evidence behind it is remarkably strong. Pimobendan for dogs is not a cure for heart disease, but it is one of the few medications proven to both improve quality of life and meaningfully extend survival time. Understanding how it works, when it should be started, and what to expect can help you feel more confident about your dog’s treatment plan.
What Is Pimobendan?
Pimobendan is a veterinary cardiac medication that belongs to a class of drugs called inodilators. That term combines two actions: it is both a positive inotrope (it strengthens the heart’s contractions) and a vasodilator (it relaxes blood vessels to reduce the workload on the heart). This dual mechanism makes it uniquely effective among heart failure drugs, because it addresses two critical problems simultaneously — a weakened heart that cannot pump efficiently, and elevated pressure in the blood vessels that forces the heart to work even harder.
The drug was first developed in the 1980s and was initially studied for use in human heart failure. However, it became far more successful in veterinary medicine, where it received approval for use in dogs and has since become a cornerstone of cardiac treatment protocols. The brand name Vetmedin is the most widely recognized formulation, available as chewable tablets that most dogs accept readily.
Pimobendan for dogs works at the cellular level by increasing the sensitivity of cardiac muscle cells to calcium — the mineral that triggers muscle contraction. Rather than flooding the cells with more calcium (which can cause dangerous side effects), pimobendan makes the existing calcium work more effectively. It also inhibits an enzyme called phosphodiesterase III in both heart muscle and blood vessel walls, which relaxes the vessels and further improves blood flow. The net result is a heart that pumps more strongly with less effort, delivering more oxygenated blood to the body while reducing the fluid backup that causes congestion in the lungs and abdomen.
When Do Veterinarians Prescribe Pimobendan?
Pimobendan is prescribed for dogs with specific types of heart disease, and the timing of when it is started has become one of the most important decisions in veterinary cardiology. The two primary conditions for which pimobendan is used are myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM).
Myxomatous Mitral Valve Disease
MMVD is the most common heart disease in dogs, accounting for roughly 75 percent of all canine cardiac cases. It occurs when the mitral valve — the valve between the left atrium and left ventricle — degenerates over time, becoming thickened and misshapen. The valve no longer closes properly, and blood leaks backward with each heartbeat. Over months to years, this regurgitation causes the heart chambers to enlarge as they try to compensate for the lost pumping efficiency. Small and medium breeds are disproportionately affected, with Cavalier King Charles Spaniels, Dachshunds, Miniature Poodles, and Chihuahuas among the most commonly diagnosed. You can explore many of these breeds in our dog breeds directory.
Dilated Cardiomyopathy
DCM is a disease of the heart muscle itself, where the walls of the heart chambers become thin and weak, and the chambers dilate (enlarge). The heart loses its ability to contract forcefully enough to maintain adequate blood flow. Large and giant breeds are most commonly affected, including Doberman Pinschers, Great Danes, Boxers, and Irish Wolfhounds. DCM often progresses more rapidly than MMVD, and pimobendan is frequently started as soon as the diagnosis is confirmed, even before overt signs of congestive heart failure appear.
The Preclinical Stage — Starting Before Symptoms Appear
One of the most significant advances in veterinary cardiology in recent years has been the recognition that starting pimobendan for dogs before they develop symptoms of heart failure can dramatically delay the onset of that failure. This approach is supported by the landmark EPIC trial (Evaluation of Pimobendan in Cardiomegaly), one of the largest and most rigorous clinical studies ever conducted in veterinary medicine.
The EPIC trial enrolled 360 dogs with MMVD and echocardiographic evidence of heart enlargement — dogs that were in Stage B2, meaning they had structural heart disease and cardiac remodeling but no clinical signs of failure. Dogs that received pimobendan in addition to standard monitoring had a median delay of 15 months before developing congestive heart failure compared to the placebo group. For a dog owner, 15 additional months of a healthy, active, symptom-free life with their companion is a profound benefit.
As a result of the EPIC trial, many veterinary cardiologists now recommend starting pimobendan at Stage B2 of MMVD — when the heart has begun to enlarge but the dog still appears completely normal. If your veterinarian detects a heart murmur and subsequent imaging shows the heart is getting bigger, the conversation about pimobendan should follow. For a deeper look at the stages and progression, see our guide on dog congestive heart failure.
How Pimobendan Is Dosed
The standard dose of pimobendan for dogs is 0.2 to 0.3 mg per kilogram of body weight, given orally twice daily — approximately every 12 hours. The medication should be administered on an empty stomach, ideally one hour before feeding. Food — particularly high-fat meals — can reduce the absorption of pimobendan by as much as 30 percent, which significantly blunts its effectiveness. This is one of the most important practical details for owners to remember: giving pimobendan with a meal or hiding it in a treat wrapped in cheese or peanut butter can undermine the drug’s benefit.
Vetmedin chewable tablets come in several sizes (1.25 mg, 2.5 mg, 5 mg, and 10 mg), making it relatively straightforward to achieve accurate dosing across a range of dog sizes — from a 3-kilogram Chihuahua to a 60-kilogram Great Dane. Your veterinarian will calculate the appropriate tablet size and may combine sizes for dogs that fall between standard increments.
Consistency matters with pimobendan. The drug has a relatively short half-life in the body (approximately 30 minutes for the parent compound, though its active metabolite persists longer), which is why twice-daily dosing is essential. Missing doses or giving them at irregular intervals can lead to fluctuations in cardiac support that are not ideal for a heart already under strain. Many owners find it helpful to set alarms or tie the medication schedule to daily routines — one dose first thing in the morning before breakfast, and one dose in the evening before dinner.
What the Research Shows: Survival Benefits
The evidence base for pimobendan for dogs is stronger than for almost any other veterinary cardiac medication. Multiple clinical trials have demonstrated clear survival benefits:
- The EPIC Trial (2016): Dogs with preclinical MMVD (Stage B2) that received pimobendan had a median time to the primary endpoint (onset of CHF or cardiac death) of 1228 days, compared to 766 days in the placebo group. This represents a 60 percent longer time before heart failure developed.
- The QUEST Study (2008): In dogs with CHF caused by MMVD, pimobendan extended median survival to 267 days compared to 140 days for dogs receiving benazepril (an ACE inhibitor) alone — nearly doubling survival time.
- The PROTECT Study (2012): In Doberman Pinschers with preclinical DCM, pimobendan delayed the onset of CHF by approximately 9 months compared to placebo, and extended overall survival time by roughly 6 months.
These are not marginal improvements. In a disease that is progressive and ultimately fatal, gaining months to over a year of additional quality life is a meaningful outcome for both dogs and their families. The consistency of the results across multiple studies, different types of heart disease, and different breed populations adds further weight to the evidence.
Side Effects and Safety Considerations
Pimobendan is generally well tolerated by most dogs, and serious side effects are uncommon at standard doses. However, no medication is entirely without risk, and owners should be aware of what to monitor.
Common Side Effects
The most frequently reported side effects of pimobendan include mild gastrointestinal signs such as decreased appetite, diarrhea, or occasional vomiting. These tend to be transient and often resolve without intervention. Some dogs may show a temporary increase in heart rate, which is an expected pharmacological effect of the drug’s positive inotropic action. In most cases, this is mild and clinically insignificant.
Less Common Concerns
In rare cases, pimobendan may contribute to arrhythmias (irregular heart rhythms), particularly in dogs that already have an underlying tendency toward abnormal electrical activity in the heart. This is one reason veterinary cardiologists often perform an electrocardiogram (ECG) before starting the medication and may recommend periodic monitoring. Dogs with certain types of obstructive heart disease — specifically hypertrophic cardiomyopathy or conditions where there is a physical obstruction to blood flow leaving the heart (such as aortic stenosis or severe subaortic stenosis) — should generally not receive pimobendan, as increasing the force of contraction can worsen the obstruction and be dangerous.
Long-Term Monitoring
Dogs on pimobendan benefit from regular veterinary check-ups that include cardiac auscultation, chest X-rays to assess lung fields and heart size, and periodic echocardiograms to evaluate heart function over time. The frequency of these visits depends on the stage of disease — dogs in preclinical stages may only need re-evaluation every four to six months, while dogs in active heart failure may require more frequent monitoring, sometimes monthly during initial stabilization.
Pimobendan as Part of a Multi-Drug Protocol
While pimobendan is powerful on its own, it is most commonly used as part of a combination therapy approach, especially once a dog has progressed to symptomatic heart failure (Stage C or beyond). The standard multi-drug protocol for canine CHF typically includes:
- Pimobendan — to strengthen heart contractions and reduce vascular resistance
- Furosemide (Lasix) — a loop diuretic that removes excess fluid from the lungs and body, relieving congestion
- ACE inhibitors (enalapril or benazepril) — to dilate blood vessels, reduce blood pressure, and decrease the hormonal signals that drive fluid retention and cardiac remodeling
- Spironolactone — a potassium-sparing diuretic that also blocks aldosterone, a hormone involved in the harmful neurohormonal activation that occurs in heart failure
Each drug addresses a different aspect of the heart failure syndrome, and together they provide more comprehensive management than any single agent can achieve. Your veterinarian will adjust the combination and doses based on your dog’s specific condition, response to treatment, and any side effects that arise.
Living with a Dog on Pimobendan
Managing a dog on pimobendan and other cardiac medications requires consistency and attentiveness, but it does not have to dominate your daily life. Most dogs on cardiac protocols continue to enjoy walks, playtime, companionship, and all the things that make life good. Here are some practical tips:
- Give pimobendan on an empty stomach — one hour before meals, twice daily. This is the single most important practical point.
- Monitor resting respiratory rate — counting your dog’s breaths per minute while they are sleeping or calmly resting is one of the best at-home tools for detecting early fluid buildup. A normal resting rate is typically under 30 breaths per minute. If it consistently rises above this threshold, contact your veterinarian.
- Keep appointments — regular cardiac rechecks allow your veterinarian to catch changes before they become crises and to adjust medications proactively.
- Moderate exercise — gentle, regular activity is usually beneficial for dogs with heart disease, but avoid strenuous exertion or exercising in heat and humidity. Let your dog set the pace.
- Low-sodium diet — your veterinarian may recommend a diet lower in sodium to help manage fluid retention, particularly in dogs with active CHF.
If you are considering adding a dog to your family and want to learn more about breeds that may be prone to heart conditions, our dog breeds directory provides detailed profiles that include common health concerns for each breed. And if you are ready to open your home to a dog in need — including senior dogs or those with manageable medical conditions — visit our adoption page to see pets currently looking for their forever family.
Breeds Most Commonly Prescribed Pimobendan
While any dog can develop heart disease, certain breeds are genetically predisposed to the conditions that pimobendan treats. Understanding breed-specific risks can help owners stay vigilant about cardiac screening.
- Cavalier King Charles Spaniel — the breed most closely associated with early-onset MMVD, with many individuals developing murmurs by middle age
- Doberman Pinscher — highly predisposed to DCM, with screening echocardiograms and Holter monitors recommended annually starting at age three to four
- Boxer — prone to arrhythmogenic right ventricular cardiomyopathy (ARVC) and DCM
- Great Dane — susceptible to DCM, with the condition often presenting in young to middle-aged adults
- Dachshund, Miniature Poodle, Chihuahua, Maltese, and Yorkshire Terrier — small breeds commonly affected by MMVD
- Irish Wolfhound — one of the giant breeds most frequently diagnosed with DCM
- Cocker Spaniel — prone to both MMVD and DCM
If your dog belongs to one of these breeds, discussing a cardiac screening schedule with your veterinarian — even if your dog currently appears healthy — is a proactive step that can lead to earlier detection and the timely initiation of pimobendan for dogs when appropriate.
Frequently Asked Questions
How long can a dog live on pimobendan?
Survival time varies significantly depending on the type and stage of heart disease, the dog’s overall health, and how well they respond to treatment. Clinical studies have shown that dogs started on pimobendan at the preclinical stage (Stage B2 MMVD) can live three or more years before developing heart failure. Dogs already in congestive heart failure (Stage C) who receive pimobendan as part of a multi-drug protocol have median survival times ranging from roughly nine months to over a year, though some dogs do considerably better. Individual outcomes vary, and your veterinarian can provide the most accurate prognosis based on your dog’s specific situation.
Can I give pimobendan with food?
Pimobendan should be given on an empty stomach, ideally one hour before a meal. Food — especially fatty food — can reduce the drug’s absorption by up to 30 percent. If your dog refuses to take the tablet without food, speak with your veterinarian about strategies, but avoid wrapping it in high-fat treats like cheese or peanut butter. Some owners find that placing the tablet directly in the back of the dog’s mouth and following with a small amount of water works well.
What happens if I miss a dose of pimobendan?
If you miss a dose, give it as soon as you remember — unless it is nearly time for the next scheduled dose, in which case skip the missed dose and resume the regular schedule. Do not double up on doses. An occasional missed dose is unlikely to cause an immediate crisis, but chronic inconsistency can reduce the drug’s effectiveness and allow heart failure symptoms to worsen. Setting phone alarms or using a pill organizer can help maintain consistency.
Is pimobendan safe for all dogs with heart disease?
Pimobendan is not appropriate for every type of heart disease. It is specifically indicated for dogs with MMVD and DCM. Dogs with hypertrophic cardiomyopathy (HCM) or obstructive conditions like severe subaortic stenosis should generally not receive pimobendan, as it can worsen the obstruction. This is why a proper cardiac workup — including echocardiography — is essential before starting the medication. Your veterinarian or a veterinary cardiologist will determine whether pimobendan is the right choice for your dog’s specific diagnosis.
Does pimobendan cure heart disease in dogs?
No. Pimobendan does not cure heart disease — it manages it. The underlying structural or muscular changes to the heart continue to progress over time. What pimobendan does is improve the heart’s ability to function despite those changes, relieve symptoms, delay the onset of heart failure, and extend survival. It is one of the most effective tools available for managing canine heart disease, but it works best as part of a comprehensive treatment plan that includes regular monitoring, appropriate diet, and other medications as needed.
How much does pimobendan cost?
The cost of pimobendan varies depending on the size of the dog (which determines the dose), the pharmacy, and whether you use the brand-name Vetmedin or a generic formulation. Monthly costs for most dogs range from approximately 30 to 80 dollars. Generic versions of pimobendan have become available in recent years, which has helped reduce costs for many owners. Your veterinarian can write a prescription that you can fill at a veterinary pharmacy or, in some regions, at a regular pharmacy that stocks veterinary medications.
Can pimobendan be used alongside other heart medications?
Yes, and in fact it almost always is. Pimobendan is routinely combined with furosemide, ACE inhibitors, and spironolactone in dogs with symptomatic heart failure. The drugs complement each other by targeting different mechanisms involved in heart failure. Your veterinarian will design the specific combination and monitor your dog for any interactions or dose adjustments that may be needed over time.
Heart disease is one of the most common serious conditions in aging dogs, but a diagnosis does not have to mean the end of good days together. With medications like pimobendan, attentive home monitoring, and a strong partnership with your veterinarian, many dogs with heart disease continue to enjoy comfortable, happy lives well beyond what was possible just a few decades ago. If you are looking to give a loving home to a dog — including one that may benefit from dedicated medical care — consider browsing our available pets and opening your door to a new companion.